Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing.
Founded in 1999, Meridian is headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research in numerous therapeutic areas, and specializes in high-volume vaccine trials.
Meridian conducts clinical studies at 16 locations across 9 cities, and is a member of the Platinum Research Network. Each Meridian site features a certified clinical physician and dedicated research personnel.
To enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.
Be the partner of choice for clinical research services in the therapeutic areas we serve, particularly for studies exploring complex and individualized medicines. Be a significant asset for pharmaceutical and biotechnology companies driving the greatest advancements in human health.
Safety: Put patients first. Make the clinical research of new therapies a positive experience for study participants and a viable investment for clients.
Integrity: Provide exceptional care to study participants, reliable performance to clients, and high-fidelity data to advance research programs.
Partnership: Establish a shared vision within the company and with clients to guide well-informed decisions and bring life-changing therapies to market faster.
Dedication: Assign the best team for every study, deliver on every promise, and exceed expectations at every opportunity.